MBL2 and Respiratory tract infection: A study of Dutch adults with recurrent respiratory tract infection revealed no significant clinical differences between subjects with or without MBL2 genotypes that predict low MBL production after subjects with subnormal serum Ig levels or suboptimal responses to 23-valent pneumococcal polysaccharide vaccine were excluded from the analyses [11].